Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
Nanorobotics
Nanorobotics Overview
Nanorobotics is a preclinical-stage startup on a mission to eradicate cancer by harnessing the power of its breakthrough, patented light-activated nanomolecular platform technology.
Nanorobotics platforms leverage the unique characteristics of a Molecular Nanomachines (MNMs), which can drill mechanically through the cell membrane, to develop a pipeline of safe and effective molecular therapies for treating cancers that have shown resistance to conventional therapies.
Nanorobotics leading molecule, MNM96, exhibits an excellent preclinical efficacy and safety profile and is well positioned to advance toward the first human clinical trials in 2025.